TRIM7 antisense RNA 2 (TRIM7-AS2)

TRIM7 antisense RNA 2 (TRIM7-AS2) is a long non-coding RNA gene located on the human genome and is transcribed antisense to the TRIM7 protein-coding gene[5]. Long non-coding antisense RNAs such as TRIM7-AS2 regulate gene expression through diverse mechanisms, including modulation of their sense gene counterpart by affecting chromatin structure, transcription, and RNA stability[6]. No evidence exists that TRIM7-AS2 encodes a protein or functions as a classical therapeutic target (like a receptor or enzyme), and there are currently no drugs that specifically target this RNA, nor is it established as a biomarker or safety concern. Functional studies for TRIM7-AS2 specifically are lacking, and existing knowledge is based on the broader role of antisense non-coding RNAs in gene regulation[6]. Note: - TRIM7-AS2 is distinct from TRIM7, the E3 ubiquitin ligase protein, which is a therapeutic target with roles in antiviral immunity, apoptosis, and inflammation[1][2][3]. - TRIM7-AS2 itself is not a classical "target" in the usual therapeutic, pharmacological, or diagnostic sense. If your intent was to find information about "TRIM7" as a protein target, please clarify, as that entity has very different and well-established therapeutic relevance[1][3].

Other names

TRIM7-AS2CTC-338M12.5